---
title: "REVBW.US (REVBW.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/REVBW.US/news.md"
symbol: "REVBW.US"
name: "REVBW.US"
parent: "https://longbridge.com/en/quote/REVBW.US.md"
datetime: "2026-03-09T23:53:49.279Z"
locales:
  - [en](https://longbridge.com/en/quote/REVBW.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/REVBW.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/REVBW.US/news.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/REVBW.US/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/REVBW.US/news.md)


# REVBW.US (REVBW.US) — Related News

### [XtalPi's AI + Robotics platform aids ReviR's rare neurological drug RTX-117; targets Charcot-Marie-Tooth disease and Vanishing White Matter disease.](https://longbridge.com/en/news/277492886.md)
*2026-03-02T15:31:42.000Z*
> ReviR has recently administered the first doses of RTX-117, a small molecule under investigation for its ability to regu

### [Revelation Biosciences - CW27 | 8-K: FY2025 Q3 Revenue: USD 0](https://longbridge.com/en/news/264736476.md)
*2025-11-06T22:40:44.000Z*
### [Revelation Biosciences - CW27 | 10-Q: FY2025 Q3 Revenue: USD 0](https://longbridge.com/en/news/264719715.md)
*2025-11-06T21:12:17.000Z*
### [Revelation Biosciences - CW27 | 8-K: FY2025 Q2 EPS: USD -7.01](https://longbridge.com/en/news/252231674.md)
*2025-08-08T12:11:32.000Z*
### [Revelation Biosciences - CW27 | 8-K: FY2025 Q1 EPS: USD -2.11](https://longbridge.com/en/news/239422056.md)
*2025-05-08T20:23:44.000Z*
### [Revelation Biosciences - CW27 | 10-Q: FY2025 Q1 EPS: USD -2.11](https://longbridge.com/en/news/239417963.md)
*2025-05-08T20:03:36.000Z*